![Xiao Tian Zhu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Xiao Tian Zhu
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
QILU Regor Therapeutics, Inc.
3
| Private Company | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Xiao Tian Zhu
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Regor Therapeutics Group
![]() Regor Therapeutics Group Miscellaneous Commercial ServicesCommercial Services Regor Therapeutics Group is a biotech company founded in 2018 by a team of scientists with expertise in drug discovery and development. The company is based in Boston, MA and has subsidiaries in China. Regor Therapeutics Group utilizes its industry-leading core strength in Rcard™ to accelerate the discovery of innovative therapeutic agents. The company has completed 8 PCCs in-house, with 5 INDs filed, and has a pipeline of leading assets in metabolism, oncology, and auto-immunity. The company's two leading assets are RGT-075, an orally bioavailable small molecule GLP1R full agonist with potential for obesity and beyond, and RGT-419B, a unique CDK4+ inhibitor showing outstanding single agent responses in refractory ER+/HER2- breast cancer patients. The company was founded in 2018, and the CEO is Xiayang Qiu. | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer |
Statistik
International
Vereinigte Staaten | 2 |
Sektoral
Commercial Services | 2 |
Operativ
Founder | 3 |
Chief Executive Officer | 2 |
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Xiayang Qiu | 2 |
Min Zhong | 2 |
Wen Ge Zhong | 1 |
- Börse
- Insiders
- Xiao Tian Zhu
- Unternehmensverbindungen